A comparative study of the effects of imeglimin add‐on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low‐dose metformin ( MEGMI‐CGM study)
Diabetes, Obesity and Metabolism · 2024
DOI: 10.1111/dom.15639 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Akihiro Takahashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metformin, Hypoglycemic Agents, Blood Glucose. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
ORCID-Profile: Hiroshi Nomoto
Zitieren
APA
Takahashi, A., Nomoto, H., Onishi, K., Manda, S., Miya, A., Kameda, H., Nakamura, A., & Atsumi, T. (2024). A comparative study of the effects of imeglimin add‐on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low‐dose metformin ( MEGMI‐CGM study). Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15639
Vancouver
Takahashi A, Nomoto H, Onishi K, Manda S, Miya A, Kameda H, et al. A comparative study of the effects of imeglimin add‐on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low‐dose metformin ( MEGMI‐CGM study). Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15639
BibTeX
@article{Takahashi2024,
author = {Takahashi, Akihiro and Nomoto, Hiroshi and Onishi, Kinnosuke and Manda, Satoru and Miya, Aika and Kameda, Hiraku and Nakamura, Akinobu and Atsumi, Tatsuya},
title = {A comparative study of the effects of imeglimin add‐on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low‐dose metformin ( MEGMI‐CGM study)},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
doi = {10.1111/dom.15639}
}
EUVIMED